MedPath
HSA Approval

MONTELAIR TABLET 10MG

SIN14788P

MONTELAIR TABLET 10MG

MONTELAIR TABLET 10MG

May 26, 2015

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

R03DC03

montelukast

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

Hovid Bhd

Active Ingredients

Montelukast Sodium 10.40mg eqv Montelukast

10mg

Montelukast

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MONTELAIR TABLET 10MG - HSA Approval | MedPath